Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.

Using immunoaffinity-purified polyclonal anti-human recombinant tumor necrosis factor alpha (TNF alpha) F(ab')2 fragments and immunohistochemical techniques, the cells that make TNF alpha were localized in the inflamed synovial tissue of patients with rheumatoid arthritis (RA) and osteoarthriti...

Descripció completa

Dades bibliogràfiques
Autors principals:	Chu, C, Field, M, Feldmann, M, Maini, R
Format:	Journal article
Idioma:	English
Publicat:	1991

Ítems similars

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
per: Deleuran, B, et al.
Publicat: (1992)

Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction.
per: Chu, C, et al.
Publicat: (1991)

Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.
per: Deleuran, B, et al.
Publicat: (1992)

Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair.
per: Chu, C, et al.
Publicat: (1992)

Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis.
per: Field, M, et al.
Publicat: (1991)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1997)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
per: Ulfgren, A, et al.
Publicat: (2000)

MT1-MMP is critical cartilage invasion promoter of pannus in human rheumatoid arthritis
per: Itoh, Y, et al.
Publicat: (2009)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
per: Williams, R, et al.
Publicat: (2000)

INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS ON CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS
per: Gibbons, D, et al.
Publicat: (1992)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
per: Feldmann, M, et al.
Publicat: (1997)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
per: Brennan, F, et al.
Publicat: (1995)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
per: Maini, R, et al.
Publicat: (1995)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
per: Maini, R, et al.
Publicat: (1998)

A Three-Dimensional Co-Culture Model for Rheumatoid Arthritis Pannus Tissue
per: Jietao Lin, et al.
Publicat: (2021-11-01)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
per: Brennan, F, et al.
Publicat: (1989)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
per: Paleolog, E, et al.
Publicat: (1996)

Carboxyamidotriazole alleviates pannus formation and cartilage erosion in rats with adjuvant arthritis
per: Yongting Zhou, et al.
Publicat: (2023-09-01)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
per: Elliot, M, et al.
Publicat: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
per: Elliott, M, et al.
Publicat: (1993)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
per: Haworth, C, et al.
Publicat: (1991)

Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
per: Brennan, F, et al.
Publicat: (1992)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1994)

Pannus growth regulators as potential targets for biological therapy in rheumatoid arthritis
per: A. S. Mikhaylova, et al.
Publicat: (2018-04-01)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
per: Davis, D, et al.
Publicat: (1997)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
per: Maini, R, et al.
Publicat: (1994)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
per: Paleolog, E, et al.
Publicat: (1998)

Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.
per: Brennan, F, et al.
Publicat: (2002)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
per: Feldmann, M
Publicat: (1996)

TNF alpha--a pivotal role in rheumatoid arthritis?
per: Brennan, F, et al.
Publicat: (1992)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
per: Taylor, P, et al.
Publicat: (2000)

Cytokine expression in rheumatoid arthritis.
per: Brennan, F, et al.
Publicat: (1991)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
per: Maini, R, et al.
Publicat: (1994)

Connective tissue growth factor-targeting DNA aptamer suppresses pannus formation as diagnostics and therapeutics for rheumatoid arthritis
per: Gan Wu, et al.
Publicat: (2022-08-01)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
per: Buchan, G, et al.
Publicat: (1988)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (2001)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
per: Elliott, M, et al.
Publicat: (1994)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
per: Feldmann, M, et al.
Publicat: (2001)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1995)

TNF alpha as a therapeutic target in rheumatoid arthritis.
per: Feldmann, M, et al.
Publicat: (1994)